Probit-analysis in the evaluation of the selectivity of antineoplastic effect of agents
Iavorskaia, N.P.
Voprosy Onkologii 17(8): 90-94
1971
ISSN/ISBN: 0507-3758 PMID: 5002550 Document Number: 43271
Document emailed within 1 workday
Related Documents
Presnova, Z.F.; Chernov, V.A. 1971: Effect of adrenomimetic agents on the antineoplastic activity of thiophosphamide Farmakologiia i Toksikologiia 34(4): 456-460Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839
Hall, T.C. 1978: Steroid carriers of cytotoxic agents: evaluation of antineoplastic effects of drugs and animal models Cancer Treatment Reports 62(8): 1263-1264
Eichenberger, T.; Trachtenberg, J.; Chronis, P.; Keating, A. 1989: Synergistic effect of ketoconazole and antineoplastic agents on hormone-independent prostatic cancer cells Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(6): 363-366
Purkayastha, S.K.; Jha, T.; Pal, D.K.; De, A.U. 1993: Possible antineoplastic agents: Part XIII. Synthesis, biological evaluation and QSAR studies of some 1-(substituted benzenesulphonyl)-5-oxopyrrolidine-2-carboxylic acid derivatives Anti-Cancer Drug Design 8(2): 95-100
Sasaki, K. 2004: The filter region of the myocardial Na channel, together with ion selectivity, controls pharmacodynamics of anti-arrhythmia agents--an analysis using the channel altered by idiopathic ventricular fibrillation Hokkaido Journal of Medical Science 79(6): 747-754
Cousineau, G.H.; Aubin, A.; Lalague, E.; Charbonneau, L.G.; Champagne, M. 1976: Evaluation of enzymatic kinetic constants with the aid of Probit transformation Laboratory Practice 25(7): 462-464
Nissen, N.I. 1972: Evaluation of the clinical effect of antineoplastic drugs Ugeskrift for Laeger 134(25): 1345-1346
Röding, H. 1978: Perforated gastric and duodenal ulcers; results of treatment by probit analysis Zentralblatt für Chirurgie 103(21): 1392-1396
Hamada, K.; Sakamoto, M.; Mikasa, K.; Teramoto, M.; Mori, K.; Tsujimoto, M.; Maeda, K.; Konishi, M.; Sawaki, M.; Narita, N.; Kita, E. 1997: Evaluation of antineoplastic effect of CAM (clarithromycin) in a mouse model inoculated with lung cancer cells Japanese Journal of Antibiotics 50 Suppl A: 28-31
Gonzálvez Sánchez, J.A.; Hernández Bravo, M.T.; Cerda Olmedo, G.; Iborra García, R.; Iborra García G [corrected to Iborra García, R.] 1994: Anticholinergic agents with gastrointestinal selectivity: are they really selective? Atencion Primaria 14(10): 1154
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3